BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2012
View Archived Issues
Phase II safety and immunogenicity data presented for West Nile vaccine
Read More
GLYX-13 has antidepressant activity without psychotomimetic effects
Read More
Plexxikon presents phase II results for PLX-3397
Read More
Enrollment completed in second phase III tedizolid phosphate trial
Read More
Inovio Pharmaceuticals reports interim data from its DNA-based flu vaccine study
Read More
Portola Pharmaceuticals begins phase II study of PRT-4445
Read More
Biotie's phase IIb tozadenant study meets endpoints
Read More
Autism Speaks awards grant to Seaside Therapeutics
Read More
Administration complete in seasonal flu vaccine phase III trial
Read More
Myriad to perform protein biomarker discovery under diabetes collaboration
Read More
OncoTherapy Science provides update on COMPETE-PC study
Read More
ONO-4059 demonstrates inhibition of arthritis severity and bone damage in vivo
Read More
German scientists disclose novel antibodies binding to claudin-6
Read More
MilleGen and INSERM prepare new human antibodies for cancer
Read More
New agents for obesity presented by Zafgen
Read More
New NS5B inhibitors patented by Bristol-Myers Squibb
Read More
Teva Pharmaceutical licenses Xenon's pain drug
Read More
Merck & Co. divulges new SYK inhibitors
Read More
FDA expands indication for Zytiga
Read More
BG Medicine obtains CE Mark for CardioSCORE test
Read More
Phase III trial of arbaclofen ER tablets for spasticity due to MS begins
Read More
Interferon alpha-2b XL shows activity similar to peginterferon alfa-2b
Read More
Phase I trial of 4SC's anticancer compound achieves all primary objectives
Read More
AstraZeneca and Isis Pharmaceuticals enter strategic alliance for cancer
Read More
Oncomatrix and University of Stuttgart form partnership
Read More
Mediator of muscle atrophy in critically ill patients identified
Read More